SERA — SERA PROGNOSTICS INC (Healthcare >> Medical Devices)
SERA FAQ
What is SERA's ROE?
SERA PROGNOSTICS INC reports a Return on Equity (ROE) of -47.53%.
What is SERA's dividend yield?
SERA PROGNOSTICS INC offers a dividend yield of 0.00%.
What is SERA's Deepscope Quality Score?
Deepscope rates SERA's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy SERA?
Deepscope's AI Timing Score for SERA is 50 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does SERA belong to?
SERA PROGNOSTICS INC is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange.
|
USD 1.93
Price
-0.07
(-3.50%)
Day Change
|
|
|---|
SERA Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 23) và Thời điểm mua ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Lịch sử ROE tương đối thấp
ROE đang giảm đáng kể
ROA quá thấp so với ROE
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Tăng trưởng ROA hiện tại đang dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Lịch sử Biên lợi nhuận ròng tương đối thấp.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt lắm , ...
| Yếu tố Chất lượng |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 96 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 1.93 |
| PBV / Sector |
1.12 / 7.44
GREAT
|
| Earning Per Share | -0.82 |
| PE / Sector |
N/A / 29.51
|
| PEG or PE/Growth / Sector |
N/A / 0.41
|
| Average 1M Daily Value |
0.16 M
GREAT
|
| Average 1W Daily Value |
0.11 M
GREAT
|
| Yếu tố Kỹ thuật |
|
42% |
| Sức khỏe tài chính |
|
45% |
| Khả năng kiếm lợi nhuận |
|
56% |
| Lợi tức cho nhà đầu tư |
|
4% |
| Chi tiết đăng ký |
| Analyze Date | 2026-06-12 09:43:11 |
| Symbol | SERA |
| Name | SERA PROGNOSTICS INC |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 38.19 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 75.58 / 18,475.95 |
| Tin tức, Dự báo ước tính |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 2749 East Parleys Way, Salt Lake City, UT, United States, 84109
Phone: 801 990 0520
Website: https://www.sera.com
Employees: 71
Sector: Healthcare >> Medical Devices
Description: Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
Google